Key Takeaways
- DSO practice sale valuation multiples apply to adjusted EBITDA after normalizing owner compensation. This adjustment often creates a significant gap between headline expectations and actual proceeds.
- Single-location practices typically trade at lower multiples than multi-location platforms, as detailed in the sections below.
- Owner compensation normalization can be one of the most consequential adjustments. Replacing the owner’s pay with a market-rate associate salary can reduce EBITDA by hundreds of thousands and directly lowers enterprise value at the chosen multiple.
- Deal structure can matter more than the headline multiple. Cash at close, rollover equity, and earnouts can materially change what the seller actually receives, which makes after-tax, after-structure modeling essential.
- McLerran & Associates delivers CPA-led, diligence-grade valuations and side-by-side DSO versus private-buyer comparisons so owners enter negotiations with defensible numbers and a clear view of both price and terms.
Get a clear picture of your practice's value — schedule a discovery call.
How DSO Practice Sale Valuation Multiples Work
Dso practice sale valuation multiples for single-location practices commonly fall in the mid-single-digit range, with sources citing roughly 4x to 8x adjusted EBITDA depending on practice quality and buyer type. Multi-location platforms commonly fall in the high-single-digit to low-double-digit range, with sources citing roughly 8x to 12x adjusted EBITDA depending on scale and quality. The multiple applies to adjusted EBITDA, after normalizing owner compensation to market rate. The distinction between reported EBITDA and adjusted EBITDA can be one of the main sources of the gap between expectation and reality.
Dso Dental Practice Valuation Multiples In 2026 provides additional context on how these ranges have evolved. Practice-level dental valuation multiples have held steady around 5x to 9x over the past two years, according to Tusk Practice Sales' Q3 2026 Dental M&A Market Report. That range offers a planning baseline once the earnings base it applies to is correctly calculated.
Why DSOs Pay Multiples: The Arbitrage Spread
DSOs are buying recurring hygiene revenue, a platform for geographic density, and the opportunity to re-trade that practice at a higher multiple when the DSO itself is sold to a larger sponsor. This dynamic is called multiple arbitrage. A practice acquired at a single-digit EBITDA multiple rolls into a platform that can re-trade at a materially higher multiple to a larger buyer.
Platform dental deals trade at 9x to 11x EBITDA versus add-ons at 5x to 8x, a spread of roughly 2 to 4 turns on the same underlying EBITDA, per Ad Astra Equity's 2026 dental valuation guide. The platform-to-add-on arbitrage spread in DSO was the widest of the eight healthcare sub-segments tracked, per Ct Acquisitions' Healthcare Services M&A Multiples Report 2026, which synthesizes data from Provident Healthcare Partners and Gf Data.
Applying a 9x to 11x platform multiple to a typical single-location practice materially overstates its likely valuation. A solo practice functions as an add-on asset rather than a platform. The buyer underwrites it that way, and the seller benefits from understanding that distinction.
Solo owner-operator general dental practices under $500K in seller's discretionary earnings traded in a 4x to 6x band in the 12 months ending June 30, 2026, while platform-tier DSO targets above $10M adjusted EBITDA traded in a 10x to 15x adjusted EBITDA band over the same window, per Provident Healthcare Partners' Q1 2026 Dental Services Sector Update and Skytale Group's 2026 Dental M&A Report. These are different assets, priced by different buyer economics, and conflating them can be one of the most common valuation mistakes sellers make.
How DSOs Value Practices: The Normalization Walkthrough
The single most important concept in a DSO sale is EBITDA normalization. This process converts a practice's reported financial results into the adjusted EBITDA figure a buyer will actually multiply. The multiple either holds or collapses at this stage, and McLerran & Associates focuses much of its work here.
The following is an illustrative example, not a promise of any specific outcome for any individual practice.
Consider a general dental practice with $2.5M in annual collections. The practice reports $700K in EBITDA on its income statement. That number looks strong, yet it is not the number a DSO buyer will use.
The owner currently pays themselves $500K per year. A market-rate associate dentist performing the same clinical work as an owner is typically underwritten at roughly 30% to 35% of net collections for general dentistry, which often equates to roughly $250K to $350K depending on specialty and geography. This range reflects the standard range DSO buyers apply when replacing the owner's reported compensation with a market-rate go-forward compensation number. The $200K difference is subtracted from reported EBITDA, not added back. The owner was effectively taking $200K of profit out of the business as excess compensation. A buyer replacing the owner with a market-rate associate treats that $200K as a real operating cost.
After that single adjustment, reported EBITDA of $700K becomes $500K. Then the buyer removes $30K in personal expenses run through the practice, such as a vehicle, club membership, and personal travel, and $20K in one-time costs that will not recur. Adjusted EBITDA lands at approximately $550K. Apply a 6x multiple, a reasonable midpoint for a well-run single-location general practice, and enterprise value is roughly $3.3M. An owner who applied the same multiple to reported EBITDA might have expected $4.2M.
The $900K gap comes from arithmetic, not negotiation tactics. McLerran & Associates works to control that gap by doing the normalization work up front, before the practice goes to market, so the number holds under buyer scrutiny and the deal does not get re-traded.
Normalization Steps in a DSO Practice Valuation
The standard normalization sequence for a dental practice sale to a DSO involves the following steps:
- Start with reported EBITDA from the practice's income statement, which equals net income plus interest, taxes, depreciation, and amortization.
- Normalize owner compensation to market rate. Replace the owner's actual pay with what a market-rate associate dentist would cost to perform the same clinical production. For general dentistry, DSO buyers typically replace the owner's reported compensation with a market-rate go-forward compensation of 30% to 35% of net collections.
- Remove personal and discretionary expenses, such as vehicles, club memberships, personal travel, and family members on payroll above market rate, each documented with invoices or payroll records.
- Remove non-recurring and one-time items, such as legal settlements, one-time equipment repairs, and similar costs that will not repeat post-close.
- Cross-reference practice management software reports against financials. Production and collections data must tell the same story as the tax returns and P&L statements. Institutional buyers run a three-year P&L review but a five-year practice management software audit, and divergences become liabilities.
- Arrive at adjusted EBITDA, which becomes the buyer-accepted earnings base to which the multiple is applied.
McLerran & Associates performs this as CPA-led, diligence-grade work up front. Every add-back is documented. Every adjustment is defensible. An add-back that cannot be documented is not an add-back; it functions as a future price reduction with a delay on it. Because the homework is done before the deal goes out, McLerran's valuations tend to hold up when buyers scrutinize them, and deals typically avoid re-trades.
How to Calculate a DSO Practice Multiple and Dental Practice Valuation for a DSO Sale: 2026 Guide provide additional detail on the mechanics of this process.
Find out what your practice is really worth — request a comprehensive practice valuation.
What Actually Moves the Multiple
Once the earnings base is normalized, the multiple applied to it depends on several practice-specific factors. Four factors can be some of the main drivers that move a single-location practice's multiple within its applicable range. Because buyers weigh these factors differently, understanding them helps an owner anticipate where they stand before a buyer tells them.
- Owner Dependence and Provider Concentration. When the founding dentist drives most production, owns key referral relationships, and remains essential to staff stability, the buyer may still pursue the practice. However, the buyer will underwrite the risk that revenue falls after the owner steps back. A practice where the owner produces the majority of collections may face a compressed multiple, a longer earnout, or both. Associate-supported production, where the owner accounts for a smaller share of total collections, can improve the multiple and simplify deal structure. Associate-led production where the owner produces less than 60% to 70% of clinical revenue can be worth an additional 0.5x to 1.5x on the multiple, per Ad Astra Equity's 2026 dental valuation guide.
- Hygiene and Recurring Revenue. Hygiene share above roughly 30% of collections signals recurring, transferable patient revenue that survives the owner's departure and tends to earn a premium in dental practice valuations. A strong hygiene program indicates patient retention, recall discipline, and a durable restorative pipeline. Buyers often underwrite these traits as lower post-close risk.
- Scale. The step from single-location to add-on to platform can be real and significant. A dentist who consolidates even two or three practices before a sale can access a meaningfully higher multiple tier, per Glacier Lake Partners' May 2026 DSO M&A guide. Scale extends beyond revenue. Management infrastructure, centralized systems, and an expanding buyer universe all contribute to a higher multiple tier.
- Provider Diversification. Provider concentration is the single biggest risk factor in dental practice M&A, per Glacier Lake Partners. A practice where one provider generates the majority of collections faces a key-person discount that can reduce enterprise value materially relative to a practice with distributed production across multiple providers. Buyers price this risk into the multiple, the earnout, or both.
For a deeper look at these factors, see 7 Key Factors That Shape Your Dso Valuation Multiple.
From Enterprise Value to Take-Home: Deal Structure Reality Check
Enterprise value rarely equals what the owner takes home. The bridge from enterprise value to actual proceeds involves several deductions that can meaningfully change the economic outcome and that vary significantly by deal structure.
Cash at close is the portion of the purchase price paid immediately at closing. DSO offers typically lead with 60% to 80% of a deal's total value paid as cash at closing, per TUSK Practice Sales' Q3 2026 Dental M&A Market Report, with the remainder in equity and earnout.
Rollover equity is the portion of the deal paid in DSO equity rather than cash. This equity can be held at the joint-venture level, where the seller retains a stake in their specific practice entity, typically with distributions. Alternatively, it can be held at the holding-company level, where the seller holds equity in the broader DSO platform. Holding-company equity offers no distributions but potentially higher upside if the platform recapitalizes at a higher multiple. Rollover equity typically converts to cash only at a future recapitalization or sale, which may be 3 to 7 years away and is not guaranteed. As much as roughly 40% of a DSO deal can be paid in equity rather than cash, which is why the owner benefits from underwriting the DSO like an investment, evaluating its profitability, growth, management team, and financial backing before accepting equity as a meaningful portion of proceeds.
Earnouts are contingent payments tied to post-close performance targets, typically measured over 12 to 36 months. If the DSO controls expenses, headcount, and pricing post-acquisition, they also control whether the earnout target is achievable. Earnout terms and measurement mechanics therefore become a critical negotiating point.
McLerran & Associates produces multi-year, multi-structure financial forecasting and cash-flow modeling across 3-, 5-, 7-, and 10-year horizons, including conservative recapitalization assumptions. This approach helps owners compare real after-tax proceeds across deal structures rather than focusing only on headline numbers. Much of a DSO deal is treated at long-term capital gains rates rather than ordinary income, which can be a meaningful tax advantage, but the allocation between goodwill, non-compete payments, and equipment affects how proceeds are taxed. This article provides education, not tax advice; owners should consult their own tax advisors for guidance specific to their situation.
Which Multiple Applies to Your Practice?
The multiple that applies to a given practice depends primarily on where it sits in the size and structure spectrum.
Single-Location Add-On. This category describes a solo practice where the owner is the primary producer, with limited associate depth and no centralized management infrastructure. This practice functions as an add-on acquisition, and a platform multiple does not apply to it. The applicable range generally sits in the lower portion of the single-location band.
Associate-Supported Single Location or Small Group. This category describes a practice with distributed production, strong hygiene, and documented systems that reduce owner dependence. This practice can earn a multiple toward the upper end of the single-location range and, in some cases, may attract add-on pricing from a DSO seeking geographic density.
Multi-Location Platform Candidate. This category describes a group with $3M or more in adjusted EBITDA, centralized management infrastructure, and a provider bench that is not dependent on any single clinician. This practice may attract platform-level pricing if it genuinely meets the operational criteria buyers use to define a platform. A platform premium is not automatic. The buyer will assess whether the group's revenue is concentrated in one location, whether any offices carry too much risk, and whether the combined EBITDA justifies the price.
Because McLerran & Associates works both the private-buyer and DSO paths in roughly equal measure, it produces a true side-by-side valuation that quantifies a practice's worth in both markets. The owner then chooses the path with full information rather than a guess. DSO EBITDA Multiples in 2026: What You Actually Take Home explores this comparison in further detail.
What To Do Before You Take a Meeting
The single most important step before meeting with a DSO is obtaining a CPA-led, diligence-grade valuation that normalizes EBITDA using the same methodology a buyer's quality-of-earnings team will apply. A "free" back-of-the-napkin number provided by a buyer or a generalist broker becomes the anchor for the entire negotiation. Once that anchor is set, it can be very difficult to move. An EBITDA number that survives the buyer's accountants intact supports the top of the multiple range, while one that gets picked apart during diligence gets re-traded. A re-trade after going exclusive with one buyer can be one of the weakest negotiating positions in the process.
McLerran & Associates has completed roughly 2,000 successful practice sales, representing approximately $2 billion in closed transaction volume, with more than 10,000 practices evaluated. That track record translates into a transaction rate of roughly 85% to 90%, compared to an industry norm closer to 35% to 40%. The difference comes from doing the valuation work correctly before the deal goes out and from running a structured, auction-like process among vetted buyers that creates competitive tension. By contrast, do-it-yourself close rates can run as low as 15% to 20%, while a well-run brokered process closes at roughly 80%.
The difference between a paid, diligence-grade valuation and a free estimate is not the fee. It is whether the number holds when a buyer's team looks under the hood and whether the deal closes at the agreed price or gets re-traded in the final weeks before closing.
Frequently Asked Questions
How Many Times EBITDA Is a Dental Practice Worth?
There is no single answer, because the multiple depends on the earnings base it is applied to, the size and structure of the practice, and the buyer type. Single-location practices generally trade in a range of roughly 5x to 8x adjusted EBITDA when sold to a DSO, while multi-location platforms with management infrastructure and distributed production can attract higher multiples. Private buyers, meaning individual dentists, typically underwrite at lower multiples than institutional buyers because their economics differ. The critical caveat is that all of these multiples apply to adjusted EBITDA, not reported EBITDA. As shown in the normalization example above, the multiple applies to the lower adjusted EBITDA figure rather than the higher reported number. The range becomes meaningful only after the earnings base is correctly calculated.
How Do You Value a Dental Practice for Sale to a DSO?
DSO buyers value a dental practice by applying a multiple to adjusted EBITDA, which represents the practice's operating profit after normalizing the owner's compensation to a market-rate associate salary, removing personal and discretionary expenses, and removing non-recurring items. The process begins with reported net income, adds back interest, taxes, depreciation, and amortization to arrive at raw EBITDA, then applies normalization adjustments to arrive at the adjusted EBITDA figure the buyer will actually multiply. The resulting enterprise value is then reduced by debt, escrow, holdbacks, and rollover equity to arrive at estimated cash at close. Every step in this process requires documentation, including payroll records, invoices, tax returns, and practice management software reports. Unsupported adjustments are disallowed during diligence and reduce the purchase price dollar for dollar, multiplied by the applicable multiple.
What Is the Arbitrage Spread Between Solo Practices and DSO Platforms?
The arbitrage spread is the difference between the multiple a DSO pays to acquire a single practice and the multiple at which the DSO itself is valued when it is sold to a larger sponsor or taken public. A DSO might acquire a single-location practice at 6x adjusted EBITDA, then have that practice's earnings revalued at 10x or higher when the DSO platform is sold. This change creates a significant gain simply through aggregation, independent of any operational improvement. This spread can be the economic engine behind DSO consolidation. It helps explain why DSOs are often willing to pay more than individual dentists for the same practice, while still paying a multiple below what the DSO itself may eventually trade for. Sellers who understand this dynamic are better positioned to negotiate, because they understand what the buyer is actually buying.
How Does Owner Compensation Normalization Change Your Multiple?
Owner compensation normalization does not change the multiple itself. It changes the earnings base to which the multiple is applied, which changes enterprise value directly and proportionally. If an owner pays themselves $500K and a market-rate associate would cost $300K, the $200K difference is subtracted from reported EBITDA. At a 6x multiple, that single adjustment reduces enterprise value by $1.2M. The normalization can also work in the owner's favor. If the owner has been underpaying themselves relative to market, which is common in S-corporation structures where distributions supplement a low salary, the adjustment may increase adjusted EBITDA. The direction and magnitude of the adjustment depend entirely on the owner's actual compensation relative to what a buyer would pay a replacement clinician. Controlling the narrative around EBITDA by doing the normalization correctly and documenting it defensibly before the buyer's team does it can be one of the highest-leverage actions a seller can take.
DSO Multiple vs. Private Buyer Multiple — Which Is Higher?
DSO and private equity buyers generally offer higher headline multiples than individual dentist buyers, because their economics differ. An individual dentist buying a practice must service acquisition debt from the practice's cash flow while also paying themselves a salary, which constrains how much they can pay. A DSO is buying recurring revenue for a platform that may be re-traded at a higher multiple, so it can justify a higher acquisition price. However, the DSO's higher headline multiple often comes with deal structure, including rollover equity, earnouts, and employment terms, that reduces the cash the seller actually receives at close. A private buyer's lower multiple may come with a cleaner, all-cash structure and no post-close employment requirement. The most useful comparison focuses on after-tax, after-structure proceeds across a realistic time horizon. McLerran & Associates produces this comparison for every client considering both paths.
Dso Multiple vs. Private Buyer Multiple: A Structural Comparison
The table below compares the four buyer types across the metrics that can most affect take-home proceeds: headline multiple, cash at close, and the structural features that determine how much of the headline price the seller actually receives.
| Buyer Type | Typical Multiple Range | Cash At Close Range | Key Structural Difference |
|---|---|---|---|
| Individual Dentist (Private Buyer) | 3.5x to 4.5x adjusted EBITDA (general practice) | ~80% of total deal value | SBA-financed, buyer constrained by debt service, typically all-cash structure with no rollover equity or earnout |
| Regional Roll-Up Dso | 5x to 7x normalized EBITDA | 70% to 80% of headline consideration | Highest cash-at-close percentage among equity-purchasing DSO buyer types, limited capital depth relative to national platforms |
| Formal Dso (Pe-Backed) | 6x to 9x normalized EBITDA | 65% to 75% of headline consideration | Rollover equity of 20% to 30% typical, equity realizes at recapitalization in roughly 3 to 5 years, earnout of 5% to 15% common |
| Platform Pe (Large-Scale) | 9x to 13x normalized EBITDA (requires $3M+ EBITDA) | 60% to 70% of headline consideration | Highest headline multiples, lowest cash-at-close percentage, rollover equity illiquid for 5 to 8 years tied to PE fund cycle |
All multiple ranges above are expressed as multiples of adjusted (normalized) EBITDA and reflect the same earnings basis. Cash at close ranges reflect the percentage of total stated consideration paid at closing, before taxes, fees, and closing adjustments. Sources: Private Practice Research's 2026 US DSO Landscape Report; Joey Friedman CPA (June 2026).
The Multiple Is the Headline, Adjusted EBITDA Is the Story
The multiple is the number that often gets quoted at conferences and in unsolicited DSO outreach letters. Adjusted EBITDA is the number that determines what the check actually looks like. The gap between headline multiple and reality, created by owner-compensation normalization, personal expense removal, deal structure, rollover equity, and earnout mechanics, can be where money is won or lost in a dental practice sale.
Owners who enter a DSO process without a defensible, CPA-led adjusted EBITDA figure are negotiating from the buyer's number. Owners who do the normalization work up front, create competition among vetted buyers, and understand the full structure of each offer, including what the rollover equity is actually worth and whether the earnout is achievable, are often the ones who maximize both price and terms.
McLerran & Associates has guided roughly 2,000 practice owners through this process, evaluated more than 10,000 practices, and closed approximately $2 billion in transaction volume, with a transaction rate of roughly 85% to 90% because the work is done correctly before the deal goes out. The firm works both the private-buyer and DSO paths in roughly equal measure, so every client receives a true side-by-side comparison rather than a recommendation shaped by which path the advisor knows best.
The biggest financial decision of a dental career benefits from the same rigor the buyer brings to the table every week.
Schedule a free, confidential discovery call with McLerran & Associates.
